Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 3.05
NUS's Cash to Debt is ranked higher than
76% of the 1425 Companies
in the Global Household & Personal Products industry.

( Industry Median: 0.74 vs. NUS: 3.05 )
NUS' s 10-Year Cash to Debt Range
Min: 0.46   Max: No Debt
Current: 3.05

Equity to Asset 0.47
NUS's Equity to Asset is ranked higher than
59% of the 1414 Companies
in the Global Household & Personal Products industry.

( Industry Median: 0.53 vs. NUS: 0.47 )
NUS' s 10-Year Equity to Asset Range
Min: 0.27   Max: 0.65
Current: 0.47

0.27
0.65
Interest Coverage 184.70
NUS's Interest Coverage is ranked higher than
81% of the 902 Companies
in the Global Household & Personal Products industry.

( Industry Median: 16.21 vs. NUS: 184.70 )
NUS' s 10-Year Interest Coverage Range
Min: 8.54   Max: 9999.99
Current: 184.7

8.54
9999.99
F-Score: 7
Z-Score: 7.24
M-Score: -2.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 17.44
NUS's Operating margin (%) is ranked higher than
92% of the 1410 Companies
in the Global Household & Personal Products industry.

( Industry Median: 5.72 vs. NUS: 17.44 )
NUS' s 10-Year Operating margin (%) Range
Min: 4.9   Max: 18.9
Current: 17.44

4.9
18.9
Net-margin (%) 11.49
NUS's Net-margin (%) is ranked higher than
90% of the 1411 Companies
in the Global Household & Personal Products industry.

( Industry Median: 3.99 vs. NUS: 11.49 )
NUS' s 10-Year Net-margin (%) Range
Min: 2.94   Max: 12.43
Current: 11.49

2.94
12.43
ROE (%) 42.50
NUS's ROE (%) is ranked higher than
98% of the 1393 Companies
in the Global Household & Personal Products industry.

( Industry Median: 7.25 vs. NUS: 42.50 )
NUS' s 10-Year ROE (%) Range
Min: 10.29   Max: 107.14
Current: 42.5

10.29
107.14
ROA (%) 20.04
NUS's ROA (%) is ranked higher than
98% of the 1408 Companies
in the Global Household & Personal Products industry.

( Industry Median: 3.78 vs. NUS: 20.04 )
NUS' s 10-Year ROA (%) Range
Min: 4.94   Max: 34.01
Current: 20.04

4.94
34.01
ROC (Joel Greenblatt) (%) 139.91
NUS's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 1406 Companies
in the Global Household & Personal Products industry.

( Industry Median: 15.04 vs. NUS: 139.91 )
NUS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 53.37   Max: 1540.45
Current: 139.91

53.37
1540.45
Revenue Growth (%) 29.50
NUS's Revenue Growth (%) is ranked higher than
96% of the 1092 Companies
in the Global Household & Personal Products industry.

( Industry Median: 5.70 vs. NUS: 29.50 )
NUS' s 10-Year Revenue Growth (%) Range
Min: -2   Max: 33
Current: 29.5

-2
33
EBITDA Growth (%) 36.30
NUS's EBITDA Growth (%) is ranked higher than
97% of the 973 Companies
in the Global Household & Personal Products industry.

( Industry Median: 2.90 vs. NUS: 36.30 )
NUS' s 10-Year EBITDA Growth (%) Range
Min: -20   Max: 47.1
Current: 36.3

-20
47.1
EPS Growth (%) 41.20
NUS's EPS Growth (%) is ranked higher than
94% of the 891 Companies
in the Global Household & Personal Products industry.

( Industry Median: 3.90 vs. NUS: 41.20 )
NUS' s 10-Year EPS Growth (%) Range
Min: -20.4   Max: 46.6
Current: 41.2

-20.4
46.6
» NUS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

NUS Guru Trades in Q2 2013

Steven Cohen 9,412 sh (New)
Pioneer Investments 55,500 sh (New)
Jim Simons 652,400 sh (+11.39%)
Paul Tudor Jones Sold Out
Joel Greenblatt 56,699 sh (-6.09%)
Chuck Royce 6,856,649 sh (-17.6%)
Jeremy Grantham 24,248 sh (-40.15%)
» More
Q3 2013

NUS Guru Trades in Q3 2013

Andreas Halvorsen 584,711 sh (New)
Pioneer Investments 72,434 sh (+30.51%)
Jim Simons 538,900 sh (-17.4%)
Steven Cohen 6,948 sh (-26.18%)
Chuck Royce 4,016,905 sh (-41.42%)
Jeremy Grantham 13,869 sh (-42.8%)
Joel Greenblatt 19,755 sh (-65.16%)
» More
Q4 2013

NUS Guru Trades in Q4 2013

Paul Tudor Jones 5,388 sh (New)
Ken Fisher 1,751 sh (New)
Ken Heebner 933,800 sh (New)
Jeremy Grantham 447,658 sh (+3127.76%)
Steven Cohen 41,304 sh (+494.47%)
Andreas Halvorsen 2,109,711 sh (+260.81%)
Joel Greenblatt Sold Out
Pioneer Investments 69,370 sh (-4.23%)
Jim Simons 318,200 sh (-40.95%)
Chuck Royce 2,187,208 sh (-45.55%)
» More
Q1 2014

NUS Guru Trades in Q1 2014

Ken Fisher Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with NUS

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Sold Out 0.06%$92.69 - $138.66 $ 88.32-25%0
Joel Greenblatt 2013-09-30 Reduce -65.16%0.1%$62.17 - $98.76 $ 88.324%19755
Joel Greenblatt 2012-12-31 Reduce -77.98%0.58%$33.05 - $48.95 $ 88.32103%63757
Joel Greenblatt 2012-09-30 Add 152.1%0.45%$36.73 - $51.01 $ 88.3298%289550
John Hussman 2012-09-30 Sold Out 0.0035%$36.73 - $51.01 $ 88.3298%0
Joel Greenblatt 2012-06-30 Add 581.07%0.34%$40.26 - $59.95 $ 88.3284%114855
John Hussman 2012-06-30 New Buy$40.26 - $59.95 $ 88.3284%4000
Joel Greenblatt 2011-09-30 Reduce -48.13%0.1%$35.5 - $45.97 $ 88.32119%19671
Joel Greenblatt 2011-06-30 Reduce -24%0.1%$28.63 - $39.09 $ 88.32154%37923
Joel Greenblatt 2011-03-31 Add 80.41%0.19%$27.81 - $32.54 $ 88.32190%49896
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Nu Skin Enterprises Inc

Can Nu Skin Keep the Wrinkles out of Earnings? - Jun 13, 2012

Founded in 1984, Nu Skin Enterprises (NUS) is a distributor in "clean" personal care products. Nu Skin has historically grown earnings at a compounded rate of 6.1% since 1998, resulting in a 2.71 billion dollar market cap. The company's earnings per share have risen from $1.49 per share in 1998, to current forecast earnings per share of approximately $3.06 for fiscal 2012. The company started paying a dividend about 11 years ago and has raised their dividend every year.

Dividend Contender: Nu Skin Enterprises

This article looks at Nu Skin Enterprises, a Dividend Contender, through the lens of the F.A.S.T. Graphs™ Fundamentals Analyzer Software Tool. Since a picture is worth a thousand words, the reader will be provided the "essential fundamentals at a glance" expressed vividly in pictures.

A Dividend Contender is defined as a company that has increased its dividend for a minimum of 10 to 24 straight years. Nu Skin Enterprises is a Dividend Contender that has raised its dividend every year for 12 consecutive years. The complete Dividend Contenders list is compiled courtesy of David Fish. (Open as an excel spreadsheet and look at the tabs on the bottom to find the Dividend Contender list.)

About Nu Skin Enterprises: from their website

"Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC® science that addresses aging at its source. The company's anti-aging products feature the new ageLOC suite of products including the ageLOC R2 nutritional supplement, ageLOC Galvanic Spa System and ageLOC Galvanic Body Spa™, as well as the ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 52 markets worldwide and has more than 860,000 independent distributors. Nu Skin is traded on the New York Stock Exchange at under the symbol "NUS."

Nu Skin Enterprises: A Dividend Contender with 12 Consecutive Years of Dividend Increases

Learning from the Past – Looking at Earnings Only

Since dividends are paid out of earnings, a clear perspective of a company's historical earnings growth record is a vital component of a dividend investor's prudent due diligence process. The following graph plots Nu Skin Enterprises' earnings per share since 1999. A quick glance to the right of the graph shows that Nu Skin Enterprises has increased earnings at a compounded rate of 6.1% (see purple circle on graph) per annum.



Earnings Determine Market Price and Dividend Income: The following earnings and price correlated F.A.S.T. Graphs™ clearly illustrates the importance of earnings to both price movement and dividend income. The earnings growth rate line or True Worth ™ line (orange line with white triangles) is correlated with the historical stock price line. On graph after graph the lines will move in tandem. If the stock price strays away from the earnings line (over or under), inevitably it will come back to earnings.

Since dividends are paid out of earnings, and therefore represent additional return on top of what the market capitalizes earnings at, they are depicted by the light blue shaded area and stacked on top of the earnings line. Therefore, a quick visual of these two important components is simultaneously revealed:

1. The additional return that dividend paying stocks provide.

2. The percentage of earnings paid to shareholders as dividends (payout ratio).

The value in this article is through carefully analyzing the earnings and price correlated fundamentally based graphs. Notice that one glance tells you how well the company has performed on an operating basis historically and how the market valued that historical performance. Therefore, the reader is free to discover whether or not current valuations make sense based on historical norms coupled with fundamental values. Instead of opinion, this article is designed to produce facts that can be analyzed to the readers investing benefit.



Performance Table: Capital Appreciation and Dividend Income Nu Skin Enterprises

The associated performance results with the earnings and price correlated graph, validates the above discussion regarding the two components of total return: capital appreciation and dividend income. Dividends are included in the total return calculation and are assumed paid, but not reinvested.

When presented separately like this, the additional rate of return a dividend paying stock produces for shareholders becomes undeniably evident. In addition to the 6.1% capital appreciation (Closing Annualized ROR), long-term shareholders of Nu Skin Enterprises would have received an additional $23,066.59 in dividends that increased their total return from 6.1% to 6.8% per annum.

(Note: Since this is a Dividend Contender it has raised its dividend every year for at least 10-24 years, therefore, negative dividend growth rates shown, if any, will be attributed to special additional dividends paid in excess of the company's regularly reported dividend rate.)



The following graph plots the historically normal PE ratio (the dark blue line) correlated with 10-year Treasury note interest. Notice that the current price earnings ratio on this quality company is as normal as it has been since 1998.



A further indication of valuation can be seen by examining a company's current price to sales ratio relative to its historical price to sales ratio. The current price to sales ratio for Nu Skin Enterprises is 1.49, which is historically high.



Looking to the Future

Extensive research has provided a preponderance of conclusive evidence that future long-term returns, and the dividend and its growth rate are a function of two critical determinants:

1. The rate of change (growth rate) of the company's earnings

2. The price or valuation you pay to buy those earnings

Therefore, forecasting future earnings growth, bought at sound valuations, is the key to safe, sound, and profitable performance.

Therefore, it logically follows that measuring performance without simultaneously measuring valuation is a job half done. At its current price, which is attractively aligned with its True Worth™ valuation, Nu Skin Enterprises represents a potential opportunity to invest in a Dividend Contender at a reasonable price. The important factor is that Nu Skin Enterprises has real assets and cash flow underpinning its stock price. This solid economic foundation offers shareholders the potential for both a strong margin of safety and an opportunity for an increasing dividend income stream and potentially attractive future returns.

The Estimated Earnings and Return Calculator Tool is a simple yet powerful resource that empowers the user to calculate and run various investing scenarios that generate precise rate of return potentialities. Thinking the investment through to its logical conclusion is an important component towards making sound and prudent commonsense investing decisions.

The consensus of 7 leading analysts reporting to Capital IQ forecast Nu Skin Enterprises long-term earnings growth at 11.7%. Nu Skin Enterprises has low long-term debt at 16% of capital. Nu Skin Enterprises is currently trading at a P/E of 15.1, which is inside the value corridor (defined by the five orange lines) of a maximum P/E of 18. If the earnings materialize as forecast, Nu Skin Enterprises's True Worth valuation would be $80.59 at the end of 2017, which would be a 13.5% annual rate of return from the current price, including assumed dividends.



Earnings Yield Estimates

Discounted Future Cash Flows: All companies derive their value from the future cash flows (earnings) they are capable of generating for their stakeholders over time. Therefore, because Earnings Determine Market Price and dividend income in the long run, we expect the future earnings of a company to justify the price we pay.

Since all investments potentially compete with all other investments, it is useful to compare investing in any prospective company to that of a comparable investment in low risk Treasury bonds. Comparing an investment in Nu Skin Enterprises to an equal investment in 10-year Treasury bonds illustrates that Nu Skin Enterprises' expected earnings would be 7.7 times that of the 10-Year T-Bond Interest. (See EYE chart below.) This is the essence of the importance of proper valuation as a critical investing component.



This report presents essential "fundamentals at a glance" on Dividend Contenders Nu Skin Enterprises, illustrating the past and present valuation based on earnings achievements as reported. Future forecasts for earnings growth are based on the consensus of leading analysts. Although with just a quick glance you can know a lot about the company, it's imperative that the reader conduct his or her own due diligence in order to validate whether the consensus estimates seem reasonable or not.

Summary & Conclusions

The Fast Graphs™ tool shows Nu Skin's stock price has recently traded near its intrinsic value after being over-priced. Nu Skins sales have continued to grow at an attractive rate over the past 15 years. In contrast to its recent Price/Sales ratio peak of 2.06 on 02/29/2012, Nu Skin is currently trading at a Price/Sales ratio of 1.49, which is high for recent years. This may be a stock to research and watch as it has just now come back into the value corridor and could be a good dividend play. As always, we recommend you conduct your own thorough due diligence.

Disclosure: No position at the time of writing.

Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment adviser as to the suitability of such investments for his specific situation. A comprehensive due diligence effort is recommended.
Check out latest stock trades

Top Ranked Articles about Nu Skin Enterprises Inc

Six Royce Reductions in Third Quarter
Guru Chuck Royce has averaged a return of 17.87% over 12 months. Using a small-cap strategy at Royce & Associate funds, Chuck Royce currently manages 1,438 stocks in total, valued at $32.3 billion. His portfolio has a quarter-over-quarter turnover rate of 6 percent. His portfolio update as of this week shows 149 new stocks. Read more...
Chuck Royce Makes Two Large Reductions
Over the past week Chuck Royce has made some notable reductions to two of his holdings. These reductions were reported by GuruFocus Real Time Picks and both occurred on Sept. 30. Real Time picks are interesting to follow because they keep you closely informed to the big moves that the gurus are making throughout the duration of a quarter. Molex (MOLXA) Read more...
The Midas Touch - Chuck Royce Second Quarter Sells
Some of Chuck Royce’s remarkable trading histories evoke the myth of King Midas whose touch turned everything to gold. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 14.90
NUS's P/E(ttm) is ranked higher than
80% of the 1168 Companies
in the Global Household & Personal Products industry.

( Industry Median: 19.30 vs. NUS: 14.90 )
NUS' s 10-Year P/E(ttm) Range
Min: 8.84   Max: 41.45
Current: 14.9

8.84
41.45
P/B 6.12
NUS's P/B is ranked lower than
69% of the 1342 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.67 vs. NUS: 6.12 )
NUS' s 10-Year P/B Range
Min: 1.74   Max: 10.1
Current: 6.12

1.74
10.1
P/S 1.71
NUS's P/S is ranked lower than
64% of the 1452 Companies
in the Global Household & Personal Products industry.

( Industry Median: 0.91 vs. NUS: 1.71 )
NUS' s 10-Year P/S Range
Min: 0.45   Max: 2.88
Current: 1.71

0.45
2.88
PFCF 15.72
NUS's PFCF is ranked higher than
73% of the 827 Companies
in the Global Household & Personal Products industry.

( Industry Median: 19.20 vs. NUS: 15.72 )
NUS' s 10-Year PFCF Range
Min: 6.16   Max: 43.41
Current: 15.72

6.16
43.41
EV-to-EBIT 8.72
NUS's EV-to-EBIT is ranked higher than
89% of the 1248 Companies
in the Global Household & Personal Products industry.

( Industry Median: 15.40 vs. NUS: 8.72 )
NUS' s 10-Year EV-to-EBIT Range
Min: 5.3   Max: 24.3
Current: 8.72

5.3
24.3
PEG 0.43
NUS's PEG is ranked higher than
94% of the 685 Companies
in the Global Household & Personal Products industry.

( Industry Median: 2.24 vs. NUS: 0.43 )
NUS' s 10-Year PEG Range
Min: 0.34   Max: 23.55
Current: 0.43

0.34
23.55
Shiller P/E 31.39
NUS's Shiller P/E is ranked higher than
52% of the 680 Companies
in the Global Household & Personal Products industry.

( Industry Median: 20.43 vs. NUS: 31.39 )
NUS' s 10-Year Shiller P/E Range
Min: 9.47   Max: 51.34
Current: 31.39

9.47
51.34

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.41
NUS's Dividend Yield is ranked lower than
62% of the 1039 Companies
in the Global Household & Personal Products industry.

( Industry Median: 2.00 vs. NUS: 1.41 )
NUS' s 10-Year Dividend Yield Range
Min: 0.86   Max: 5.05
Current: 1.41

0.86
5.05
Dividend Payout 0.20
NUS's Dividend Payout is ranked higher than
84% of the 849 Companies
in the Global Household & Personal Products industry.

( Industry Median: 0.37 vs. NUS: 0.20 )
NUS' s 10-Year Dividend Payout Range
Min: 0.2   Max: 0.85
Current: 0.2

0.2
0.85
Dividend growth (3y) 33.90
NUS's Dividend growth (3y) is ranked higher than
95% of the 565 Companies
in the Global Household & Personal Products industry.

( Industry Median: 4.90 vs. NUS: 33.90 )
NUS' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 33.9
Current: 33.9

0
33.9
Yield on cost (5-Year) 4.63
NUS's Yield on cost (5-Year) is ranked higher than
85% of the 1071 Companies
in the Global Household & Personal Products industry.

( Industry Median: 2.13 vs. NUS: 4.63 )
NUS' s 10-Year Yield on cost (5-Year) Range
Min: 2.84   Max: 16.68
Current: 4.63

2.84
16.68
Share Buyback Rate 1.60
NUS's Share Buyback Rate is ranked higher than
91% of the 794 Companies
in the Global Household & Personal Products industry.

( Industry Median: -0.70 vs. NUS: 1.60 )
NUS' s 10-Year Share Buyback Rate Range
Min: 5   Max: -2.7
Current: 1.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.92
NUS's Price/Tangible Book is ranked lower than
78% of the 1200 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.86 vs. NUS: 7.92 )
NUS' s 10-Year Price/Tangible Book Range
Min: 1.23   Max: 23.93
Current: 7.92

1.23
23.93
Price/DCF (Projected) 1.64
NUS's Price/DCF (Projected) is ranked higher than
62% of the 645 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.50 vs. NUS: 1.64 )
NUS' s 10-Year Price/DCF (Projected) Range
Min: 0.4   Max: 2.56
Current: 1.64

0.4
2.56
Price/Median PS Value 1.35
NUS's Price/Median PS Value is ranked lower than
61% of the 1313 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.10 vs. NUS: 1.35 )
NUS' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 2.64
Current: 1.35

0.41
2.64
Price/Peter Lynch Fair Value 0.59
NUS's Price/Peter Lynch Fair Value is ranked higher than
87% of the 365 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.50 vs. NUS: 0.59 )
NUS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.29   Max: 3.52
Current: 0.59

0.29
3.52
Price/Graham Number 2.25
NUS's Price/Graham Number is ranked lower than
60% of the 1015 Companies
in the Global Household & Personal Products industry.

( Industry Median: 1.40 vs. NUS: 2.25 )
NUS' s 10-Year Price/Graham Number Range
Min: 0.63   Max: 5.69
Current: 2.25

0.63
5.69
Earnings Yield (Greenblatt) 11.50
NUS's Earnings Yield (Greenblatt) is ranked higher than
89% of the 1309 Companies
in the Global Household & Personal Products industry.

( Industry Median: 6.30 vs. NUS: 11.50 )
NUS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.1   Max: 19
Current: 11.5

4.1
19
Forward Rate of Return (Yacktman) 35.38
NUS's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 888 Companies
in the Global Household & Personal Products industry.

( Industry Median: 7.11 vs. NUS: 35.38 )
NUS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -7.2   Max: 36.3
Current: 35.38

-7.2
36.3

Business Description

Industry: Consumer Packaged Goods » Household & Personal Products
Compare:LRLCY, KMB, RBGPF, EL, UNLRY » details
Traded in other countries:NUS.Germany
Nu Skin Enterprises, Inc., is a Delaware Corporation. It operates as a direct selling company with operations in 53 markets. The Company develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. It conducts business using a direct selling model in all of its markets with the exception of Mainland China where it operates through a modified business model with sales force of sales employees and sales promoters. The Company offers personal care products in the areas of core systems, targeted treatments, total care, cosmetics and its specialty botanical-based Epoch line.The Company's categories in this product line are core skin-care systems and targeted treatment products that target specific skin needs. Products in this category include ageLOC Galvanic Spa System, ageLOC Galvanic Body Spa, ageLOC Galvanic Spa Body Shaping Gel and ageLOC Dermatic Effects Body Contouring Lotion and ageLOC Transformation anti-aging skin care system. It markets various nutritional products comprised of comprehensive nutritional products, targeted solution supplements and weight management products under the Pharmanex brand. The Company competes with other direct selling organizations; these direct selling companies in its existing markets are Herbalife, Mary Kay, Oriflame, Melaleuca, Avon, Forever Living and Amway. It competes for new distributors based on the strength of its multiple business opportunities, product offerings, global compensation plan, management, and its international operations. The Company's business is subject to various laws and regulations globally, in particular with respect to network marketing activities, cosmetics, and nutritional supplements.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide